These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 33786442)
41. Prevalence and clinical manifestations of macrolide resistant Lee E; Cho HJ; Hong SJ; Lee J; Sung H; Yu J Korean J Pediatr; 2017 May; 60(5):151-157. PubMed ID: 28592978 [TBL] [Abstract][Full Text] [Related]
42. Paediatric critical illness associated with respiratory infection: a single-centre, retrospective cohort study. Alfaraidi H; Luinstra K; Eshaghi A; Smieja M; Gubbay JB; Pernica JM BMJ Paediatr Open; 2020; 4(1):e000640. PubMed ID: 32411832 [TBL] [Abstract][Full Text] [Related]
43. Functional Outcomes at 1 Year After PICU Discharge in Critically Ill Children With Severe Sepsis. Sankar J; Moodu S; Kumar K; Sankar MJ; Kabra SK; Lodha R Pediatr Crit Care Med; 2021 Jan; 22(1):40-49. PubMed ID: 33031352 [TBL] [Abstract][Full Text] [Related]
44. [Analysis of the clinical features and the risk factors of severe adenovirus pneumonia in children]. Huang H; Chen Y; Ma LY; Yan MM; Deng Y; Zhang WD; Yuan Y; Xiong P; Fang F; Liu TL Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):14-19. PubMed ID: 33396998 [No Abstract] [Full Text] [Related]
45. Characteristics of Long-Stay Patients in a PICU and Healthcare Resource Utilization After Discharge. Boerman GH; Haspels HN; de Hoog M; Joosten KF Crit Care Explor; 2023 Sep; 5(9):e0971. PubMed ID: 37644970 [TBL] [Abstract][Full Text] [Related]
46. Outcomes of Day 1 Multiple Organ Dysfunction Syndrome in the PICU. Typpo K; Watson RS; Bennett TD; Farris RWD; Spaeder MC; Petersen NJ; Pediatr Crit Care Med; 2019 Oct; 20(10):914-922. PubMed ID: 31589198 [TBL] [Abstract][Full Text] [Related]
48. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Lee H; Yun KW; Lee HJ; Choi EH Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389 [TBL] [Abstract][Full Text] [Related]
49. Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia. Chiu CY; Chen CJ; Wong KS; Tsai MH; Chiu CH; Huang YC J Microbiol Immunol Infect; 2015 Feb; 48(1):51-6. PubMed ID: 23927825 [TBL] [Abstract][Full Text] [Related]
50. Outcomes of Children With Critical Bronchiolitis Meeting at Risk for Pediatric Acute Respiratory Distress Syndrome Criteria. Slain KN; Rotta AT; Martinez-Schlurmann N; Stormorken AG; Shein SL Pediatr Crit Care Med; 2019 Feb; 20(2):e70-e76. PubMed ID: 30461577 [TBL] [Abstract][Full Text] [Related]
51. The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia. Cilloniz C; Albert RK; Liapikou A; Gabarrus A; Rangel E; Bello S; Marco F; Mensa J; Torres A Am J Respir Crit Care Med; 2015 Jun; 191(11):1265-72. PubMed ID: 25807239 [TBL] [Abstract][Full Text] [Related]
52. Observational clinical study on organ dysfunction associated with dosing of antibiotics in a Pediatric Intensive Care Unit. Tafelski S; Gratopp A; Richter F; Kramer S; Spies C; Wernecke KD; Nachtigall I Minerva Pediatr; 2018 Aug; 70(4):331-339. PubMed ID: 27830927 [TBL] [Abstract][Full Text] [Related]
53. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Bréchot N; Luyt CE; Schmidt M; Leprince P; Trouillet JL; Léger P; Pavie A; Chastre J; Combes A Crit Care Med; 2013 Jul; 41(7):1616-26. PubMed ID: 23563585 [TBL] [Abstract][Full Text] [Related]
54. Mortality Risk Using a Pediatric Quick Sequential (Sepsis-Related) Organ Failure Assessment Varies With Vital Sign Thresholds. Peters C; Murthy S; Brant R; Kissoon N; Görges M Pediatr Crit Care Med; 2018 Aug; 19(8):e394-e402. PubMed ID: 29939978 [TBL] [Abstract][Full Text] [Related]
55. Severe pneumonia by Mycoplasma as an adverse event of everolimus therapy in patients with tuberous sclerosis complex. Flores-González JC; Estalella-Mendoza A; Lechuga-Sancho AM; Quintero-Otero S; Rubio-Quiñones F; Hernández-González A; Saldaña-Valderas M Eur J Paediatr Neurol; 2016 Sep; 20(5):758-60. PubMed ID: 27215926 [TBL] [Abstract][Full Text] [Related]
56. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju. Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608 [TBL] [Abstract][Full Text] [Related]
57. The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children. Zheng B; Zhao J; Cao L BMC Infect Dis; 2020 Jun; 20(1):391. PubMed ID: 32487034 [TBL] [Abstract][Full Text] [Related]
58. Association of Wei J; Wu S; Jin X; Zhang J; Pan S Allergol Immunopathol (Madr); 2022; 50(1):31-36. PubMed ID: 34873894 [TBL] [Abstract][Full Text] [Related]
59. Aetiology and outcome of severe community-acquired pneumonia in children admitted to a paediatric intensive care unit. Delport SD; Brisley T S Afr Med J; 2002 Nov; 92(11):907-11. PubMed ID: 12506595 [TBL] [Abstract][Full Text] [Related]
60. Clinical characteristics of children with Mycoplasma pneumoniae infection hospitalized during the Danish 2010-2012 epidemic. Sørensen CM; Schønning K; Rosenfeldt V Dan Med J; 2013 May; 60(5):A4632. PubMed ID: 23673264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]